1Angelika H,Wilma L,Gerde F,et al.Natriuretic peptides as markers of mild forms of left ventricular dysfunction:effects of assays on diagnosis performance of markers[J].Clin Chem,2004;50(8):1174-83.
2Valli N,Georges A,Corcuff JB,et al.Assessment of brain natriuretic peptide in patients with suspected heart failure:comparison with radionuclide ventriculography data.Clin Chim Acta,2001,306:19-26.
3McDonagh TA,Robb SD,Murdoch DR,et al.Biochemical detection of left-ventricular systolic dysfunction.Lancet,1998,351:9-13.
4Bruneau BG, Piazza LA, de Bold AJ. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol, 1997,273:2678-2686.
5Wiese S, Breyer T, Dragu A, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myoeardium: influence of angiotensin Ⅱ and diastolic fiber length. Circulation ,2000,102:3074-3079.
6Nishimori T, Tsujino M, Sato K, et al. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J Mol Cell Cardiol, 1997,29: 2125-2130.
7Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Horm Metab Res, 1999,31:487-498.
8Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal probrain natriuretic peptide and adrenomedullin : new neurohormonal predictors of left ventricular function and prognosis after myocardial infarctiorL Circulation, 1998,87 : 1921-1929.
9Remme WJ, Swedberg K. Task force report: guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22 : 1527-1560.
10Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurment of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347 : 161-167.
2Lira TK, Hayat SA, Gaze D, et al. Independent value of echocar-diography and N-terminal pro-naCiured peptide for the prediction of major outcomes in patients with suspected heart failure [J]. Am J Cardiol, 2007, 100(5): 870-875.
3Bettencourt P, Ferreira A, Dias P. Predictors of prognos is in patients with stable mild to moderate heart falurc [J]. J Card Fail, 2000, 6: 306-313.
4Kragelung, C, Gronning, B, Kober L, et al. N-terminal pro-B-type nalriurctic peptide and longterm mortality in stable coronary heart disease [J]. N Eenl J Med, 2005: 352: 666-675.
